Aspire-Lakewood Holdings, Inc.
ASBPW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire-Lakewood Holdings, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $145.4K in total; no superinvestor holds it.
Other share classesASBP
Q4 2023 vs. Q3 2023
How the institutions holding Aspire-Lakewood Holdings, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 40 | 37 | −3 |
| Shares | 9.39M | 8.97M | −424.4K (−4.5%) |
| Value | $494.7K | $590.3K | +$95.6K (+19.3%) |
New holders (1)
Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| JPMorgan Chase & Co | – | $6.00K | 0.00% |
Sold out (4)
Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Radcliffe Capital Management, L.P. | 163,800 | $8.12K |
| Sage Rock Capital Management LP | 160,076 | $8.12K |
| HGC Investment Management Inc. | 100,000 | $5.07K |
| UBS Group AG | 453 | $23 |